Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: A possible injury pathway contributing to chronic allograft rejection

Journal of Heart and Lung Transplantation

Volumn 21, Issue 11, 2002, Pages 1174-1187

  Wu, Gordon D ^a   Jin, Yang Sun ^a   Salazar, Roberto ^a   Dai, Wang De ^a   Barteneva, Natasha ^b   Barr, Mark L ^a   Barsky, Lura W ^b   Starnes, Vaughn A ^a   Cramer, Donald V ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; APOPTOSIS; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; CYTOTOXICITY; ENDOTHELIUM CELL; GRAFT REJECTION; GRAFT SURVIVAL; HEART GRAFT; HEART TRANSPLANTATION; IMMUNE RESPONSE; LYMPHOCYTE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; ORGAN DONOR; PATHOGENESIS; PRIORITY JOURNAL; RAT; RECIPIENT; VASCULAR ENDOTHELIUM;

ANIMALS; APOPTOSIS; CYTOTOXICITY TESTS, IMMUNOLOGIC; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; GRAFT REJECTION; HEART TRANSPLANTATION; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; ISOANTIBODIES; MALE; RATS; RATS, INBRED F344; RATS, INBRED LEW; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036845789     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(02)00457-6     Document Type: Article

References (50)

1. Auchincloss H. Jr, Sachs D.H. Transplantation and graft rejection. Paul W.E., Fundamental Immunology. 2nd ed:1989;889-922 Raven Press, New York.
2. Cramer D.V. Graft arteriosclerosis in heart transplantation. Xanthus Intelligence Unit Report No. 13. 1993;R.G. Landes, Austin, TX.
3. Cramer D.V., Shirwan H. The importance of humoral immune responses in chronic rejection. Transplant Rev. 12:1998;166-176.
4. Crisp S.J., Dunn M.J., Rose M.L., et al. Antiendothelial antibodies after heart transplantation the accelerating factor in transplant-associated coronary artery disease? J Heart Lung Transplant. 13:1994;81-92.
5. Tanaka H., Sukhova G.K., Libby P. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb. 14:1994;734-745.
6. Cramer D.V., Chapman F.A., Wu G.D., et al. Cardiac transplantation in the rat. II. Alteration of the severity of donor graft arteriosclerosis by modulation of the host immune response. Transplantation. 50:1990;554-558.
7. Wu G.D., Tuan T.-L., Jin Y.-S., et al. Donor tissue responses to chronic rejection evidence for persistent antibody injury, endothelial cell activation and differential expression of extracellular matrix remodeling enzymes in heart allografts . Transplantation. 69:2000;S348.
8. Klempnauer J., Steiniger B., Luck R., Gunther E. Genetic control of rat heart allograft rejection effect of different MHC and non-MHC incompatibilities . Immunogenetics. 30:1989;81-88.
9. Hume D.M., Merrill J.P., Miller B.F., et al. Experiences with renal homotransplantation in the human report of nine cases . J Clin Invest. 34:1955;327-332.
10. Hess M.L., Hastillo A., Mohanakumar T., et al. Accelerated atherosclerosis in cardiac transplantation role of cytotoxic B-cell antibodies and hyperlipidemia . Circulation. 68:1983;II94-101.
11. Reed E.F., Hong B., Ho E., et al. Monitoring of soluble HLA alloantigens and anti-HLA antibodies identifies heart allograft recipients at risk of transplant-associated coronary artery disease. Transplantation. 61:1996;566-572.
12. Hammond E.H., Yowell R.L., Nunoda S., et al. Vascular (humoral) rejection in heart transplantation pathologic observations and clinical implications . J Heart Transplant. 8:1989;430-443.
13. Rose E.A., Smith C.R., Petrossian G.A., et al. Humoral immune responses after cardiac transplantation correlation with fatal rejection and graft arteriosclerosis . Surgery. 106:1989;203-208.
14. Baldwin W.M. III, Soulillou J.P., Claas F.H.J., et al. Antibodies to endothelial antigens in eluates of 88 human kidneys correlation with graft survival and presence of T- and B-cell antibodies . Transplant Proc. 13:1981;1547-1550.
15. Shirwan H. Chronic allograft rejection. Do the Th2 cells preferentially induced by indirect alloantigen recognition play a dominant role? Transplantation. 68:1999;715-726.
16. Cramer D.V., Qian S., Harnaha J.B., et al. Cardiac transplantation in the rat. I. The effect of histocompatibility differences on graft arteriosclerosis. Transplantation. 47:1989;414-419.
17. Russell P.S., Chase C.M., Winn H.J., et al. Coronary atherosclerosis in transplanted mouse hearts II. Importance of humoral immunity . J Immunol. 152:1994;5135-5141.
18. Russell P.S., Chase C.M., Colvin R.B. Alloantibody- and T cell-mediated immunity in the pathogenesis of transplant arteriosclerosis lack of progression to sclerotic lesions in B cell-deficient mice . Transplantation. 64:1997;1531-1536.
19. Shi C., Russell M.E., Bianchi C., et al. Murine model of accelerated transplant arteriosclerosis. Circ Res. 75:1994;199-207.
20. Cramer D.V., Wu G.D., Chapman F.A., et al. Lymphocyte subsets and histopathologic changes associated with the development of heart transplant arteriosclerosis. J Heart Lung Transplant. 11:1992;458-466.
21. Shirwan H., Leamer M., Wang H.K., et al. Peptides derived from α-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection. Transplantation. 59:1995;401-410.
22. Shirwan H., Wu G.D., Barwari L., et al. Induction of allograft nonresponsiveness following intrathymic inoculation with donor class I allopeptides. 2. Evidence for persistent chronic rejection despite high levels of donor chimerism. Transplantation. 64:1997;1671-1676.
23. Wu G.D., Cramer D.V., Chapman F.A., et al. Genetic control of the humoral immune response to xenografts. I. Functional characterization of rat monoclonal antibodies to hamster heart xenografts. Transplantation. 60:1995;1497-1503.
24. Shirwan H., Mhoyan A., Leamer M., et al. The role of donor class I major histocompatibility complex peptides in the induction of allograft tolerance. Transplant Proc. 29:1997;1134-1135.
25. Shin Y.T., Adams D.H., Wynerc L.R., et al. Intrathymic tolerance in the Lewis-to-F344 chronic cardiac allograft rejection model. Transplantation. 59:1995;1647-1653.
26. Eton D., Terramani T.T., Wang Y., et al. Genetic engineering of stent grafts with a highly efficient pseudotyped retroviral vector. J Vasc Surg. 29:1999;863-873.
27. Wu G.D., Fujii G., Johnson E., et al. Failure of anti-Forssman antibodies to induce rejection of mouse heart xenografts. Xenotransplantation. 6:1999;90-97.
28. Aubry J.-P., Blaecke A., Lecoanet-Henchoz S., et al. Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry. 37:1999;197-204.
29. Lippke J.A., Gu Y., Sarnecki C., et al. Identification and characterization of CPP32/Mch2 homolog 1, a novel cysteine protease similar to CPP32. J Biol Chem. 271:1996;1825-1828.
30. Rosen A., Casciola-Rosen L. Macromolecular substrates for the ICE-like proteases during apoptosis. J Cell Biochem. 64:1997;50-54.
31. Gill T.J. III, Natori T., Salgar S.K., Kunz H.W. Current status of the major histocompatibility complex in the rat. Transplant Proc. 27:1995;1495-1500.
32. Stephenson S.P., Morley R.C., Butcher G.W. Genetics of the rat CT system its apparent complexity is a consequence of cross-reactivity between the distinct MHC class I antigens RT1.C and RT1 . J Immunogenetics. 12:1985;101-114.
33. Haustein D., Stock W., Gunther E. Rat major histocompatibility RT1.C antigens of restricted tissue distribution consist of two polypeptide chains with molecular weights of about 42000 and 12500. Immunogenetics. 15:1982;271-277.
34. Katz S.M., Leibert M., Gill T.J.I., et al. The relative roles of MHC and non-MHC genes in heart and skin allograft survival. Transplantation. 36:1983;96-101.
35. Russell M.E., Wallace A.F., Hancock W.W., et al. Upregulation of cytokines associated with macrophage activation in the LEWIS-to-F344 rat transplantation model of chronic cardiac rejection. Transplantation. 59:1995;572-578.
36. Hancock W.W., Shi G.W., Picard M.H., et al. LEW-to-F344 carotid artery allografts analysis of a rat model of posttransplant vascular injury involving cell-mediated and humoral responses . Transplantation. 60:1995;1565-1572.
37. de Heer E., Davidoff A., van der Wal A., et al. Chronic renal allograft rejection in the rat. Transplantation-induced antibodies against basement membrane antigens. Lab Invest. 70:1994;494-502.
38. Derhaag J.G., Duijvestijn A.M., Damoiseaux J.G., et al. Effects of antibody reactivity to major histocompatibility complex (MHC) and non-MHC alloantigens on graft endothelial cells in heart allograft rejection. Transplantation. 69:2000;1899-1906.
39. Joyce S., Flye M.W., Mohanakumar T. Characterization of kidney cell-specific, non-major histocompatibility complex alloantigen using antibodies eluted from rejected human renal allografts. Transplantation. 46:1988;362-369.
40. Harris P.E., Bian H., Reed E.F. Induction of high affinity fibroblast growth factor receptor expression and proliferation in human endothelial cells by anti-HLA antibodies a possible mechanism for transplant atherosclerosis . J Immunol. 159:1997;5697-5704.
41. Kissmeyer-Neilson F., Olsen S., Petersen V.P., Fjeldborg O. Hyperacute rejection of kidney allografts associated with pre-existing humoral antibodies against donor cells. Lancet. 2:1966;662-665.
42. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 119:1992;493-501.
43. Szabolcs M., Michler R.E., Yang X., et al. Apoptosis of cardiac myocytes during cardiac allograft rejection. Relation to induction of nitric oxide synthase. Circulation. 94:1996;1665-1673.
44. Dong C., Granville D.J., Tuffnel C.E., et al. Bax and apoptosis in acute and chronic rejection of rat cardiac allografts. Lab Invest. 79:1999;1643-1653.
45. Bergese S.D., Klenotic S.M., Wakely M.E., et al. Apoptosis in murine cardiac grafts. Transplantation. 63:1997;320-325.
46. Shaddy R.E. Apoptosis in heart transplantation. Coron Artery Dis. 8:1997;617-621.
47. Adams D.H., Tilney N.L., Collins J.J., Karnovsky M.J. Experimental graft arteriosclerosis. Transplantation. 53:1992;1115-1119.
48. Bombeli T., Schwartz B.R., Harlan J.M. Endothelial cells undergoing apoptosis become proadhesive for nonactivated platelets. Blood. 93:1999;3831-3838.
49. Tilney N.L., Whitley W.D., Diamond J.R., et al. Chronic rejection an undefined conundrum. Transplantation. 52:1991;389-398.
50. Hruban R.H., Beschorner W.E., Baumgartner W.A., et al. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Amer J Path. 137:1990;871-882.